Straumann® SLActive®

SLActive® is based on the scientifically proven SLA® topography. In addition, it has a hydrophilic surface chemistry which promotes initial healing and osseointegraton with excellent survival and success rates of 97% or higher.

*Selected Publications Straumann® SLActive®

Immediate and Early Loading of Chemically Modified Implants in Posterior Jaws: 3-Year Results from a Prospective Randomized Multicenter Study.

Nicolau P, Korostoff J, Ganeles J, Jackowski J, Krafft T, Neves M, Divi J, Rasse M, Guerra F, Fischer K. Clin Implant Dent Relat Res. 2013 Aug;15(4):600-12. doi: 10.1111/j.1708-8208.2011.00418.x. Epub 2011 Dec 15. PMID:22171722.

Early osseointegration to hydrophilic and hydrophobic implant surfaces in humans.

Lang NP, Salvi GE, Huynh-Ba G, Ivanovski S, Donos N, Bosshardt DD. Clin Oral Implants Res. 2011 Apr;22(4):349-56. doi: 10.1111/j.1600-0501.2011.02172.x.PMID:21561476.

Early loading at 21 days of non-submerged titanium implants with a chemically modified sandblasted and acid-etched surface: 3-year results of a prospective study in the posterior mandible.

Bornstein MM, Wittneben JG, Brägger U, Buser D. J Periodontol. 2010 Jun;81(6):809-18. doi: 10.1902/jop.2010.090727. PMID:20450357.

Bone regeneration in dehiscence-type defects at non-submerged and submerged chemically modified (SLActive) and conventional SLA titanium implants: an immunohistochemical study in dogs.

Schwarz F, Sager M, Ferrari D, Herten M, Wieland M, Becker J. J Clin Periodontol. 2008 Jan;35(1):64-75. Epub 2007 Nov 21. PMID:18034854.

The role of nanostructures and hydrophilicity in osseointegration: In-vitro protein-adsorption and blood-interaction studies.

Kopf BS, Ruch S, Berner S, Spencer ND, Maniura-Weber K. J Biomed Mater Res A. 2015 Jan 28. doi: 10.1002/jbm.a.35401

*Selected publications. No guarantee of completeness.